Literature DB >> 9933439

Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts.

B Berse1, J A Hunt, R J Diegel, P Morganelli, K Yeo, F Brown, R A Fava.   

Abstract

Vascular endothelial growth factor (VEGF) is abundant in synovium and synovial fluids, where it probably contributes to vascular permeability and angiogenesis in arthritic joints. To investigate the probable sources of VEGF in synovium, we compared the ability of several cytokines (TGF-beta, platelet-derived growth factor (PDGF), IL-1, tumour necrosis factor (TNF), basic fibroblast growth factor (bFGF) that are associated with arthritis and angiogenesis, to stimulate secretion of VEGF protein by human synovial fibroblasts. TGF-beta was the strongest inducer of VEGF secretion; six times more VEGF was secreted when cells were stimulated by TGF-beta than when stimulated by PDGF or IL-1 for 24 h. TNF-alpha and bFGF did not stimulate any secretion of VEGF. The stimulatory effects of TGF-beta and IL-1 on VEGF secretion were additive. Hypoxic culture alone also stimulated VEGF secretion, but more importantly, hypoxic culture conditions doubled the rate of VEGF secretion stimulated by the cytokines TGF-beta and IL-1. When dermal and synovial fibroblasts were stimulated identically by hypoxia and cytokines (TGF-beta and IL-1), synovial fibroblasts secreted four times more VEGF than did dermal fibroblasts. Thus in rheumatoid arthritis, the capacity of synovial fibroblasts in the hypoxic environment to secrete large amounts of VEGF in response to cytokines such as TGF-beta probably contributes significantly to angiogenesis in the synovium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933439      PMCID: PMC1905193          DOI: 10.1046/j.1365-2249.1999.00775.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Development of time-resolved immunofluorometric assay of vascular permeability factor.

Authors:  K T Yeo; T M Sioussat; J D Faix; D R Senger; T K Yeo
Journal:  Clin Chem       Date:  1992-01       Impact factor: 8.327

2.  Superoxide radical generation by inflamed human synovium after hypoxia.

Authors:  R E Allen; D R Blake; N B Nazhat; P Jones
Journal:  Lancet       Date:  1989-07-29       Impact factor: 79.321

3.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.

Authors:  B Berse; L F Brown; L Van de Water; H F Dvorak; D R Senger
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

4.  Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.

Authors:  D T Connolly; D M Heuvelman; R Nelson; J V Olander; B L Eppley; J J Delfino; N R Siegel; R M Leimgruber; J Feder
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

5.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

Authors:  D R Senger; S J Galli; A M Dvorak; C A Perruzzi; V S Harvey; H F Dvorak
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

6.  Determinants of synovial fluid lactate concentration.

Authors:  M J James; L G Cleland; A M Rofe
Journal:  J Rheumatol       Date:  1992-07       Impact factor: 4.666

7.  Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis.

Authors:  A E Koch; L A Harlow; G K Haines; E P Amento; E N Unemori; W L Wong; R M Pope; N Ferrara
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

8.  A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium.

Authors:  C R Stevens; D R Blake; P Merry; P A Revell; J R Levick
Journal:  Arthritis Rheum       Date:  1991-12

9.  Active and latent forms of transforming growth factor beta activity in synovial effusions.

Authors:  R Fava; N Olsen; J Keski-Oja; H Moses; T Pincus
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

10.  Angiogenesis inhibition suppresses collagen arthritis.

Authors:  D J Peacock; M L Banquerigo; E Brahn
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

View more
  43 in total

Review 1.  The role of angiogenesis in rheumatoid arthritis: recent developments.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 2.  Antagonising angiogenesis in rheumatoid arthritis.

Authors:  P E Brenchley
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 3.  Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.

Authors:  P E Brenchley
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

Review 4.  Angiogenesis as a target in rheumatoid arthritis.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 5.  Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens.

Authors:  Laure Guenin-Macé; Reid Oldenburg; Fabrice Chrétien; Caroline Demangel
Journal:  Cell Mol Life Sci       Date:  2014-01-21       Impact factor: 9.261

6.  Transforming growth factor beta2 induced pleurodesis is not inhibited by corticosteroids.

Authors:  Y C Lee; C J Devin; L R Teixeira; J T Rogers; P J Thompson; K B Lane; R W Light
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

7.  Antidicer RNAse activity of monocyte chemotactic protein-induced protein-1 is critical for inducing angiogenesis.

Authors:  Arpita Roy; Miaojun Zhang; Yasser Saad; Pappachan E Kolattukudy
Journal:  Am J Physiol Cell Physiol       Date:  2013-09-18       Impact factor: 4.249

8.  In vitro mechanical vibration down-regulates pro-inflammatory and pro-fibrotic signaling in human vocal fold fibroblasts.

Authors:  David Hortobagyi; Tanja Grossmann; Magdalena Tschernitz; Magdalena Grill; Andrijana Kirsch; Claus Gerstenberger; Markus Gugatschka
Journal:  PLoS One       Date:  2020-11-19       Impact factor: 3.240

9.  Synovial tissue hypoxia and inflammation in vivo.

Authors:  C T Ng; M Biniecka; A Kennedy; J McCormick; O Fitzgerald; B Bresnihan; D Buggy; C T Taylor; J O'Sullivan; U Fearon; D J Veale
Journal:  Ann Rheum Dis       Date:  2010-05-03       Impact factor: 19.103

10.  Differential effect of IL-1β and TNFα on the production of IL-6, IL-8 and PGE2 in fibroblast-like synoviocytes and THP-1 macrophages.

Authors:  Hyun Mi Choi; Da Hee Oh; Jun Soo Bang; Hyung-In Yang; Myung Chul Yoo; Kyoung Soo Kim
Journal:  Rheumatol Int       Date:  2009-08-21       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.